NutriSystem (NASDAQ:NTRI) announced that its board has initiated a stock repurchase plan, which authorizes the company to repurchase $75.00 million in shares on Tuesday, October 30th. This repurchase authorization authorizes the company to repurchase up to 7.7% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.
Shares of NTRI opened at $37.57 on Friday. NutriSystem has a fifty-two week low of $26.06 and a fifty-two week high of $55.10. The company has a market capitalization of $1.11 billion, a PE ratio of 19.17, a price-to-earnings-growth ratio of 1.79 and a beta of 1.04.
NutriSystem (NASDAQ:NTRI) last announced its quarterly earnings results on Tuesday, October 30th. The company reported $0.54 earnings per share for the quarter, hitting the consensus estimate of $0.54. NutriSystem had a net margin of 8.06% and a return on equity of 43.46%. The firm had revenue of $159.30 million during the quarter, compared to analysts’ expectations of $164.18 million. During the same quarter in the prior year, the company earned $0.49 EPS. The company’s revenue was up .8% compared to the same quarter last year. As a group, research analysts expect that NutriSystem will post 2.12 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 19th. Stockholders of record on Friday, November 9th will be given a $0.25 dividend. The ex-dividend date is Thursday, November 8th. This represents a $1.00 annualized dividend and a dividend yield of 2.66%. NutriSystem’s payout ratio is presently 51.02%.
Several equities research analysts have issued reports on NTRI shares. Zacks Investment Research raised shares of NutriSystem from a “hold” rating to a “buy” rating and set a $45.00 price objective for the company in a research report on Thursday, August 2nd. B. Riley boosted their price objective on shares of NutriSystem from $52.00 to $53.00 and gave the company a “buy” rating in a research report on Tuesday, July 31st. Barrington Research reissued a “hold” rating on shares of NutriSystem in a research report on Friday, October 5th. BidaskClub raised shares of NutriSystem from a “sell” rating to a “hold” rating in a research report on Saturday, October 13th. Finally, DA Davidson cut shares of NutriSystem from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $45.00 to $40.00 in a research report on Tuesday, July 31st. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company’s stock. NutriSystem has a consensus rating of “Hold” and a consensus target price of $45.57.
NutriSystem Company Profile
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a D' kit that offers individuals with or at risk of type 2 diabetes.
Featured Article: Price to Earnings Ratio (PE)
Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.